Gelteq Limited (GELS)
NCM · Healthcare · Drug Manufacturers - Specialty & Generic
$0.99
-35.29%
Closing price as of 2026-06-12 · Source: TEK2day Finance
Key Metrics
Market Cap
$10.6M
Shares Outstanding
10.7M
Exchange
NCM
Currency
USD
About Gelteq Limited
Gelteq Limited focuses on developing and commercializing white label gel-based delivery solutions for humans and animals in the United States of America and Australia. It offers edible gels for prescription drugs, nutraceuticals, pet care, and other products, as well as for sports and over-the-counter products. Gelteq Limited was incorporated in 2017 and is headquartered in Clayton, Australia.
Annual Financials
| Metric | 2022-06-30 | 2023-06-30 | 2024-06-30 | 2025-06-30 |
|---|---|---|---|---|
| Revenue | 148K | 80K | 0.00 | 166K |
| Gross Profit | 53K | 31K | 0.00 | |
| Operating Income | -3.2M | -3.4M | -2.6M | -5.0M |
| Net Income | -3.4M | -3.5M | -3.5M | -6.6M |
| Diluted EPS | $-0.36 | $-0.37 | $-0.38 | $nan |